What is the workup for hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Hypercalcemia

The initial workup for hypercalcemia should include corrected calcium calculation, intact parathyroid hormone (iPTH), phosphorus, magnesium, renal function tests, 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels, and urinary calcium/creatinine ratio to differentiate PTH-dependent from PTH-independent causes. 1

Initial Assessment

  1. Calculate corrected calcium if ionized calcium is not available:

    • Formula: Corrected calcium = Total calcium + 0.8 × (4.0 - serum albumin) 1
  2. Measure intact parathyroid hormone (iPTH):

    • Most important initial test to differentiate causes 1, 2
    • Elevated/normal iPTH → PTH-dependent causes (primarily hyperparathyroidism)
    • Suppressed iPTH (<20 pg/mL) → PTH-independent causes (malignancy, etc.)
  3. Additional essential laboratory tests:

    • Phosphorus (typically low in hyperparathyroidism)
    • Magnesium
    • Renal function tests (BUN, creatinine)
    • 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels
    • Urinary calcium/creatinine ratio (helps identify familial hypocalciuric hypercalcemia)

Diagnostic Algorithm Based on PTH Results

If PTH is elevated or inappropriately normal:

  • Primary hyperparathyroidism is likely (responsible for ~90% of hypercalcemia cases along with malignancy) 1, 2
  • Consider familial hypocalciuric hypercalcemia if urinary calcium is low 1, 3
  • Check for lithium use or thiazide diuretics (can cause PTH-dependent hypercalcemia)

If PTH is suppressed:

  1. Evaluate for malignancy (second most common cause) 1, 2

    • Check PTH-related peptide (PTHrP)
    • Consider appropriate imaging based on symptoms/clinical suspicion
    • Look for anemia (common in malignancy-associated hypercalcemia) 4
  2. Assess for vitamin D disorders:

    • Check 25(OH)D levels (>150 ng/mL suggests vitamin D toxicity) 1
    • Evaluate for granulomatous disorders (sarcoidosis, tuberculosis) 1
    • Consider lymphoma (can cause vitamin D-mediated hypercalcemia) 1, 4
  3. Review medication history:

    • Vitamin A or D supplements
    • Calcium supplements
    • Thiazide diuretics
    • Lithium
    • SGLT2 inhibitors
    • Immune checkpoint inhibitors 2

Clinical Correlation

  • Mild hypercalcemia (total calcium <12 mg/dL):

    • Often asymptomatic or with subtle symptoms like fatigue and constipation 1, 2
    • Typically seen in primary hyperparathyroidism
    • Usually present for >6 months 4
  • Severe hypercalcemia (total calcium ≥14 mg/dL):

    • More likely to be symptomatic with nausea, vomiting, dehydration, confusion 2
    • Often associated with malignancy
    • Usually rapid in onset 4
    • Requires more urgent intervention

Special Considerations

  • Kidney stones and hyperchloremic metabolic acidosis suggest hyperparathyroidism 4
  • Anemia with hypercalcemia suggests malignancy 4
  • Familial hypocalciuric hypercalcemia should be considered in patients with:
    • Family history of hypercalcemia
    • Low urinary calcium excretion
    • Mildly elevated or normal PTH 1, 3

Common Pitfalls to Avoid

  1. Failing to correct calcium for albumin when ionized calcium is unavailable 1
  2. Not measuring PTH as the first diagnostic step 1, 2, 3
  3. Overlooking medication-induced causes of hypercalcemia 1, 2
  4. Missing familial hypocalciuric hypercalcemia, which requires no treatment 1
  5. Focusing only on common causes without considering rarer etiologies in challenging cases 1

Follow-up Testing

  • For patients with mild hypercalcemia, monitor serum calcium and phosphorus at least every 3 months 1
  • If primary hyperparathyroidism is diagnosed, evaluate for end-organ damage:
    • Bone density scan
    • Renal ultrasound for nephrolithiasis
    • 24-hour urine for calcium excretion 1

The diagnostic approach to hypercalcemia should be systematic, starting with PTH measurement to guide further testing. Primary hyperparathyroidism and malignancy account for 90% of cases, but other causes should be considered when clinical presentation is atypical.

References

Guideline

Hypercalcemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

[Differential diagnosis of hypercalcemia in adults].

Medizinische Klinik (Munich, Germany : 1983), 2000

Research

Hypercalcemia: an evidence-based approach to clinical cases.

Iranian journal of kidney diseases, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.